Skip to main content
. 2023 Dec 1;9(4):e003485. doi: 10.1136/rmdopen-2023-003485

Table 2.

Traditional risk factors in patients with inflammatory arthritis compared with healthy controls

CV risk factors IA (n=2050) RA (n=1308) PsA (n=356) SpA (n=386) Controls (n=939)
BMI 25.3 (22.8–28.4) 25.3 (22.6–28.7) 26.3 (23.5–29.4) 24.8 (23.0–27.7) 24.4 (22.1–17.7)
Smoking status
 Current, >1×/week 197 (10) 136 (10) 21 (6) 40 (10) 49 (5)
 Current, <1×/week 58 (3) 31 (2) 8 (2) 19 (5) 22 (2)
 Quit 925 (45) 599 (46) 166 (47) 160 (42) 379 (40)
 Never 716 (35) 442 (34) 136 (38) 138 (36) 411 (44)
Alcohol
 Yes 1165 (57) 719 (55) 215 (60) 231 (60) 669 (71)
 Incidental 442 (22) 288 (22) 66 (19) 88 (23) 170 (18)
 Never 386 (19) 263 (20) 62 (17) 61 (16) 82 (9)
Exercise (min/week) 420 (211–720) 420 (181–740) 420 (220–660) 390 (210–653) 490 (220–660)
 <30 min/day 534 (26) 359 (27) 83 (23) 92 (24) 160 (17)
 30–60 min/day 535 (26) 314 (24) 103 (29) 118 (31) 247 (26)
 >60 min/day 981 (48) 635 (49) 170 (48) 176 (46) 532 (57)
Hypertension 770 (38) 496 (38) 140 (39) 134 (35) 231 (25)
 Antihypertensives 411 (20) 268 (21) 80 (23) 63 (16) 131 (14)
Dyslipidaemia 641 (31) 422 (32) 110 (31) 109 (28) 207 (22)
 Lipid-lowering medication 335 (16) 222 (17) 59 (17) 54 (14) 98 (10)
Diabetes mellitus 109 (5) 67 (5) 26 (7) 16 (4) 13 (1)
 Antidiabetics 46 (2) 28 (2) 10 (3) 8 (2) 6 (1)
Anticoagulants 246 (12) 179 (14) 34 (10) 33 (9) 74 (8)

Data are reported as mean±SD, median (inner quartiles) or frequency (percentage) where appropriate.

BMI, body mass index; CV, cardiovascular ; IA, inflammatory arthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, (axial) spondyloarthritis.